Cargando…

Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis

Objectives: Compound Kushen injection (CKI) combined with intraperitoneal chemotherapy (IPC) is widely used in the treatment of malignant ascites (MA). However, evidence about its efficacy and safety remains limited. This review aimed to evaluate the efficacy and safety of CKI combined with IPC for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hui-Bo, Hu, Jia-Qi, Han, Bao-Jin, Cao, Hui-Juan, Chen, Shun-Tai, Chen, Xin, Xiong, Hong-Tai, Gao, Jin, Du, Yan-Yuan, Zheng, Hong-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020185/ https://www.ncbi.nlm.nih.gov/pubmed/36937874 http://dx.doi.org/10.3389/fphar.2023.1036043

Ejemplares similares

Compound Kushen Injection Protects Skin From Radiation Injury via Regulating Bim
por: Zheng, Jianxiao, et al.
Publicado: (2021)

A System Pharmacology Model for Decoding the Synergistic Mechanisms of Compound Kushen Injection in Treating Breast Cancer
por: Li, Yi, et al.
Publicado: (2021)

The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis
por: Ma, Xiao, et al.
Publicado: (2016)

The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis
por: Lin, Zhixian, et al.
Publicado: (2022)

Compound Kushen Injection Induces Immediate Hypersensitivity Reaction Through Promoting the Production of Platelet-Activating Factor via de Novo Pathway
por: Gao, Yuan, et al.
Publicado: (2021)

Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
por: Jiao, Jie, et al.
Publicado: (2020)

Effects of compound Kushen injection on pathology and angiogenesis of tumor tissues
por: Wang, Hongyan, et al.
Publicado: (2019)

Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis
por: Guo, Yu-ming, et al.
Publicado: (2015)

Is Palliative Laparoscopic Hyperthermic Intraperitoneal Chemotherapy Effective in Patients with Malignant Hemorrhagic Ascites?
por: de Mestier, Louis, et al.
Publicado: (2012)

Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia
por: Tu, Honglei, et al.
Publicado: (2016)

Exploring the nucleotide molecular mechanism of compound kushen injection for lung adenocarcinoma based on network pharmacology and molecular docking
por: Ye, Zhangpeng, et al.
Publicado: (2022)

Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis
por: Dou, Dou, et al.
Publicado: (2020)

Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection With Transcriptome Analysis
por: Shen, Hanyuan, et al.
Publicado: (2019)

Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology
por: Meng, Ziqi, et al.
Publicado: (2019)

Compound Kushen injection reduces severity of radiation-induced gastrointestinal mucositis in rats
por: Harata-Lee, Yuka, et al.
Publicado: (2022)

Efficacy and safety of compound Kushen injection combined with chemotherapy on postoperative Patients with breast cancer: A meta-analysis of randomized controlled trials
por: Ao, Man, et al.
Publicado: (2019)

The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms
por: Cui, Jian, et al.
Publicado: (2020)

Compound Kushen Injection for gastric cancer: A protocol of systematic review and meta-analysis
por: Huang, Zhihong, et al.
Publicado: (2019)

Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology
por: Zhou, Wei, et al.
Publicado: (2020)

Compound kushen injection for multiple myeloma: A protocol of systematic review and meta-analysis
por: Yang, Xinwei, et al.
Publicado: (2019)

Cell cycle arrest is an important mechanism of action of compound Kushen injection in the prevention of colorectal cancer
por: Sun, Jie, et al.
Publicado: (2022)

Conversion therapy of gastric cancer with massive malignant ascites and ovarian metastases by systemic and intraperitoneal chemotherapy
por: Kondo, Tomohiro, et al.
Publicado: (2016)

Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway
por: Jin, Yanxia, et al.
Publicado: (2018)

Compound Kushen injection attenuates angiotensin II-mediated heart failure by inhibiting the PI3K/Akt pathway
por: Wang, Wei, et al.
Publicado: (2023)

Antioxidant and Immunity Activities of Fufang Kushen Injection Liquid
por: Zhou, Shen-Kang, et al.
Publicado: (2012)

Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle
por: Aung, T. N., et al.
Publicado: (2019)

Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics
por: Qu, Zhipeng, et al.
Publicado: (2016)

The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics
por: Zhang, Yiting, et al.
Publicado: (2023)

Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer
por: Liu, Xinkui, et al.
Publicado: (2022)

Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients
por: Wu, Yinbing, et al.
Publicado: (2016)

Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect
por: He, Ruirong, et al.
Publicado: (2020)

Treatment of gestational choriocarcinoma and massive ascites by hypothermic intraperitoneal perfusion chemotherapy guided by ultrasound followed by cytoreductive surgery
por: Ba, Ming-Chen, et al.
Publicado: (2013)

Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Yu, Lixiu, et al.
Publicado: (2017)

mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
por: Zhang, Yumei, et al.
Publicado: (2022)

Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection
por: Cui, Jian, et al.
Publicado: (2019)

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites
por: Kou, Furong, et al.
Publicado: (2021)

Clinical Effectiveness and Safety of Chinese Herbal Medicine Compound Kushen Injection as an Add-On Treatment for Breast Cancer: A Systematic Review and Meta-Analysis
por: Lai, Bao-Yong, et al.
Publicado: (2022)

A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification
por: Liu, Shuyu, et al.
Publicado: (2020)

Survival and complications of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with intra-abdominal malignancies: A meta-analysis of randomized controlled trials
por: Jian, Changchun, et al.
Publicado: (2023)

Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
por: Yang, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iu9ur8rnbde36aaj5unvf4i5et